Group ID|Group Name|Treatment Sequence|Treatment Age|Treatment Type|Treatment Quantity|Treatment Unit|Treatment Application|Treatment Remarks|No of individuals in study|Species|Strain|Sex|Age|Group Endpoints|Individual ID|Group ID|Age at death|Pathology type |Pathology location|Pathology Description|
13-20-1|Sr-a-kBq 0,n/a|Sequence:1, Age:70,Type:none (controls),Quantity:0,Unit:unit code not relevant,Application:not applicable or not supplied, Remarks:n/a|50 (0 in ERA)|Mouse|Mouse, CBA/S (CBA/SU)|Male|Young Adult|acute effects|No information on individuals available for this study
13-20-2|Sr-l-kBq 0,n/a|Sequence:1, Age:70,Type:none (controls),Quantity:0,Unit:unit code not relevant,Application:not applicable or not supplied, Remarks:n/a|50 (0 in ERA)|Mouse|Mouse, CBA/S (CBA/SU)|Male|Young Adult|late effects|No information on individuals available for this study
13-20-3|Sr-a-kBq 11.1,n/a|Sequence:1, Age:70,Type:Sr-90 nitrate,Quantity:11.1,Unit:kilobecquerels per g animal,Application:Injection, intravenous, Remarks:single injection|50 (0 in ERA)|Mouse|Mouse, CBA/S (CBA/SU)|Male|Young Adult|acute effects|No information on individuals available for this study
13-20-4|Sr-l-kBq 11.1,n/a|Sequence:1, Age:70,Type:Sr-90 nitrate,Quantity:11.1,Unit:kilobecquerels per g animal,Application:Injection, intravenous, Remarks:single injection|50 (0 in ERA)|Mouse|Mouse, CBA/S (CBA/SU)|Male|Young Adult|late effects|No information on individuals available for this study
		
